According to Aurobindo Pharma 's latest financial reports the company's current revenue (TTM) is $3.33 B. In 2022 the company made a revenue of $3.01 B a decrease over the years 2021 revenue that were of $3.17 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $3.33 B | 10.73% |
2022 | $3.01 B | -5.15% |
2021 | $3.17 B | -3.88% |
2020 | $3.30 B | 7.15% |
2019 | $3.08 B | 16.99% |
2018 | $2.63 B | 6.03% |
2017 | $2.48 B | 9.96% |
2016 | $2.26 B | 10.44% |
2015 | $2.04 B | 11.87% |
2014 | $1.83 B | 50.77% |
2013 | $1.21 B | 20.39% |
2012 | $1.00 B |